Berkshire's 107% EPS Surge: Real Business Turnaround or Insurance Whiplash?

The EPS headline matters less than the durability of Berkshire's profits

The key question in Berkshire's latest update is not whether the company can produce another dramatic EPS headline. With the upcoming August 8 earnings report still ahead and last quarter's 119% increase in net earnings already creating an extreme backdrop, the more important issue is whether Berkshire's profits are becoming more durable.

What investors are really judging

Berkshire's operating earnings and net earnings have always told different parts of the same story. Last quarter, operating earnings grew 18% year over year while net earnings rose much more sharply, helped by investment gains and losses. Bulls can argue that volatility is inherent in a conglomerate built on insurance float and a huge public portfolio. Bears can argue that even a business as large as Berkshire is still subject to sharp earnings swings, which makes the quality of headline growth harder to rely on.

Why capital deployment matters more than the EPS headline

The deeper issue is what management does with Berkshire's massive liquidity cushion. The company entered the quarter with nearly $400 billion in cash and short-term investments. That is not just a dry-powder stash; it shapes expectations around future returns. With Greg Abel's strategy now under closer scrutiny in his second earnings release, investors are testing whether Berkshire can turn that balance-sheet strength into productive acquisitions and steadier confidence rather than letting it become a drag on returns.

What actually drove Berkshire's first-quarter improvement

The cleaner read is that Berkshire's underlying earnings power improved, but the quarter looks more like a favorable mix of insurance, currency, and cash yield than proof that every segment turned the corner.

Operating earnings improved, and insurance helped

Berkshire posted 18% operating earnings growth in the first quarter. That is a real improvement, and some of the strength appeared in insurance underwriting, which matters because it reflects core business performance rather than portfolio noise.

But the same quarter also benefited from favorable foreign-currency translation and from interest and dividend income. In other words, part of the earnings lift came from exchange-rate effects and from earnings on the large portfolio and cash holdings already on the balance sheet. That is constructive, but it is not the same as a broad-based turnaround across the entire conglomerate.

Why this was partly a cash-and-mix effect

Berkshire carried $397 billion in cash and short-term investments at the last reporting point. On a balance sheet of that size, even a modest yield can produce a large dollar contribution. So a stronger quarter does not automatically mean BNSF, Berkshire Hathaway Energy, and the manufacturing, service, and retailing businesses all improved in lockstep.

There is a second-order implication investors should not miss: the larger the cash pile, the more Berkshire's results can be lifted by safe income while the market waits for major deployment. Bulls view that as stored energy. Skeptics see a lower-return burden. This quarter suggests both views have merit, but it also shows that previously held assets helped support the print, not just fresh business momentum.

The audit reinforces the numbers, not the valuation thesis

Because this debate is partly about quality, the audit opinion matters. The external auditors said the 2025 financial statements present fairly, in all material respects Berkshire's financial position and results, and that the company maintained effective internal control over financial reporting. That does not settle questions about future returns or valuation, but it does support the reliability of the reported numbers.

The practical takeaway is straightforward: trust the improvement, but do not overgeneralize it. The next report needs to show whether insurance strength and cash yield can keep supporting the print while the rest of the business base stabilizes.

Berkshire's real challenge is scale, not strategy

At this size, Berkshire is judged less as a simple compounder and more as a capital allocator with an enormous buffer. With $397 billion in cash and short-term investments, the question is no longer whether Berkshire can find good businesses. It is whether it can still find enough large-scale opportunities at acceptable returns before the cash pile starts to weigh on expectations. That is why the upcoming August 8 earnings report matters now: investors want evidence of a deployment framework, not just another large liquidity balance.

Recent deals show Berkshire is not frozen

The bear case starts with scale: when dry powder approaches $400 billion, small and medium deals do not come close to absorbing it. The bull case, however, is that Berkshire has not stood still. It completed its acquisition of OxyChem earlier this year and later announced plans to acquire Taylor Morrison Home Corporation for $8.5 billion.

OxyChem matters because it shows Berkshire can still move when a strategic fit appears. Taylor Morrison is a tougher signal. Bulls can read it as a disciplined purchase of an established business with tangible assets and current earnings. Bears can read it as taking cyclical risk in a weak part of the housing market. For now, it is better treated as a debate point than as definitive proof of renewed allocator brilliance.

What would strengthen the bull case

On the upcoming August 8 earnings report, the bullish case improves if management gives investors a clearer framework for deploying capital at Berkshire's scale. The most useful signals would be:

• a repeatable approach to acquisitions that fits Berkshire's size and discipline
• evidence that new deals can earn acceptable returns without overreaching
• clearer operating stabilization across major business groups, so growth is not dependent on cash yield or currency effects alone

What would strengthen the bear case

The bear case gets stronger if:

• liquidity keeps rising without meaningful deployment
• management offers no credible path to scaling capital into productive assets
• operating earnings fail to justify the size of the balance-sheet cushion

My base case is selectively constructive. Berkshire still looks capable, and the OxyChem and Taylor Morrison moves show it is not operationally frozen. But that view depends on follow-through. The core invalidation is simple: too much idle cash, not enough productive deployment, and operating earnings that cannot justify the scale of the balance-sheet buffer.